BACKGROUND: Patients with end-stage renal disease (ESRD) requiring chronic haemodialysis who undergo coronary artery bypass graft surgery (CABG) are at significant risk for perioperative mortality. However, the impact of changes in ESRD patient volume and characteristics over time on operative outcomes is unclear. METHODS: Using the Nationwide Inpatient Sample database (1988-03), we evaluated rates of CABG surgery with and without concurrent valve surgery among ESRD patients and outcomes including in-hospital mortality, and length of hospital stay. Multivariate regression models were used to account for patient characteristics and potential cofounders. RESULTS: From 1988 to 2003, annual rates of CABG among ESRD patients doubled from 2.5 to 5 per 1000 patient-years. Concomitantly, patient case-mix changed to include patients with greater co-morbidities such as diabetes, hypertension and obesity (all P < 0.001). Nonetheless, among ESRD patients, in-hospital mortality rates declined nearly 6-fold from over 31% to 5.4% (versus 4.7% to 1.8% among non-ESRD), and the median length of in-hospital stay dropped in half from 25 to 13 days (versus 14 to 10 days among non-ESRD). CONCLUSIONS: Since 1988, an increasing number of patients with ESRD have been receiving CABG in the USA. Despite increasing co-morbidities, operative mortality rates and length of in-hospital stay have declined substantially. Nonetheless, mortality rates remain almost 3-fold higher compared to non-ESRD patients indicating a need for ongoing improvement.
BACKGROUND:Patients with end-stage renal disease (ESRD) requiring chronic haemodialysis who undergo coronary artery bypass graft surgery (CABG) are at significant risk for perioperative mortality. However, the impact of changes in ESRDpatient volume and characteristics over time on operative outcomes is unclear. METHODS: Using the Nationwide Inpatient Sample database (1988-03), we evaluated rates of CABG surgery with and without concurrent valve surgery among ESRDpatients and outcomes including in-hospital mortality, and length of hospital stay. Multivariate regression models were used to account for patient characteristics and potential cofounders. RESULTS: From 1988 to 2003, annual rates of CABG among ESRDpatients doubled from 2.5 to 5 per 1000 patient-years. Concomitantly, patient case-mix changed to include patients with greater co-morbidities such as diabetes, hypertension and obesity (all P < 0.001). Nonetheless, among ESRDpatients, in-hospital mortality rates declined nearly 6-fold from over 31% to 5.4% (versus 4.7% to 1.8% among non-ESRD), and the median length of in-hospital stay dropped in half from 25 to 13 days (versus 14 to 10 days among non-ESRD). CONCLUSIONS: Since 1988, an increasing number of patients with ESRD have been receiving CABG in the USA. Despite increasing co-morbidities, operative mortality rates and length of in-hospital stay have declined substantially. Nonetheless, mortality rates remain almost 3-fold higher compared to non-ESRDpatients indicating a need for ongoing improvement.
Authors: Edward L Hannan; Chuntao Wu; Thomas J Ryan; Edward Bennett; Alfred T Culliford; Jeffrey P Gold; Alan Hartman; O Wayne Isom; Robert H Jones; Barbara McNeil; Eric A Rose; Valavanur A Subramanian Journal: Circulation Date: 2003-07-28 Impact factor: 29.690
Authors: Daniel E Weiner; Hocine Tighiouart; Manish G Amin; Paul C Stark; Bonnie MacLeod; John L Griffith; Deeb N Salem; Andrew S Levey; Mark J Sarnak Journal: J Am Soc Nephrol Date: 2004-05 Impact factor: 10.121
Authors: K Ivens; F Gradaus; P Heering; F C Schoebel; M Klein; H D Schulte; B E Strauer; B Grabensee Journal: Int Urol Nephrol Date: 2001 Impact factor: 2.370
Authors: Donal N Reddan; Lynda Anne Szczech; Robert H Tuttle; Linda K Shaw; Robert H Jones; Steve J Schwab; Mark Stafford Smith; Robert M Califf; Daniel B Mark; William F Owen Journal: J Am Soc Nephrol Date: 2003-09 Impact factor: 10.121
Authors: Darlene Gabaldon; Zhi Xhu; Stuart B Pett; Yijuan Sun; Emmanuel I Agaba; Karen S Servilla; Glen H Murata; Antonios H Tzamaloukas Journal: Int Urol Nephrol Date: 2012-04-15 Impact factor: 2.370
Authors: Benjamin R Griffin; Patrick D Kohtz; Michael Bronsert; T Brett Reece; Joseph C Cleveland; David A Fullerton; Sarah Faubel; Muhammad Aftab Journal: J Surg Res Date: 2019-11-27 Impact factor: 2.192
Authors: Wan-Hsiang Hu; Luis Carlos Cajas-Monson; Samuel Eisenstein; Lisa Parry; Sonia Ramamoorthy Journal: Int J Colorectal Dis Date: 2015-08-05 Impact factor: 2.571
Authors: Yeonhee Lee; Jiwon Park; Myoung-Jin Jang; Hong Ran Moon; Dong Ki Kim; Kook-Hwan Oh; Kwon Wook Joo; Chun Soo Lim; Yon Su Kim; Ki Young Na; Seung Seok Han Journal: Medicine (Baltimore) Date: 2019-05 Impact factor: 1.817